National Technology & Engineering Solutions of Sandia, LLC

University of California

Kenneth Sale

Blake A Simmons

Joseph S Schoeniger

Yooli Kim Light

Brooke Nicole Harmon

Edwin A Saada

Mary Bao Tran-Gyamfi

Michael Liszka

Amanda C Kohler

Specific and broad-spectrum inhibitory peptides to CRISPR Cas9 variants (SpyCas9, SauCas9, and CjeCas9) are disclosed. A method of making and using these peptides with therapeutic CRISPR Cas9 (to improve desired targeting) or against harmful CRISPR Cas9 components (already active in a patient) is also disclosed. The peptides combined with a delivery system is also disclosed.

Peptide inhibitors of CRISPR-Cas9

In one aspect, the present invention provides a method for preparing a sugar composition. The method includes: forming a mixture including polysaccharide biomass and an ionic liquid solution, wherein the ionic liquid solution contains water and an ionic liquid, and wherein the ionic liquid contains a dicarboxylic acid anion and a cation. The pH of the mixture is greater than or equal to about 10, and the molar ratio of the dicarboxylic acid anion to the cation is at least about 1:2. The method further includes: maintaining the mixture under conditions sufficient to dissolve at least a portion of the polysaccharide present in the polysaccharide biomass; reducing the pH of the mixture containing the dissolved polysaccharide to at least about 7; adding at least one glycoside hydrolase to the mixture having the reduced pH.

Switchable ionic liquids for biomass pretreatment and enzymatic hydrolysis

Described herein are stable hybrid peroxidases capable of oxidizing manganese and high-reduction potential substrates, methods of generating such peroxidases, and method of using the peroxidases in reactions that are less environmentally toxic.

Hybrid peroxidases with enhanced activity and stability

Growing community of inventors

Livermore, CA, United States of America

Kenneth Sale